Home >> MARKETPLACE >> Copan gets third clearance for Colibrí system

Copan gets third clearance for Colibrí system

image_pdfCreate PDF

March 2024—Copan Diagnostics announced the third FDA 510(k) clearance for its Colibrí automated ID/AST preparation instrument. The in vitro diagnostic specimen preparation system has been cleared to prepare MALDI-TOF targets for qualitative identification and microbial suspension for the Beckman Coulter MicroScan WalkAway antimicrobial susceptibility testing system for qualitative testing of isolated colonies of Gram-negative and Gram-positive bacterial species grown on solid culture media.

The Colibrí system received 510(k) clearances in 2022 for use with MALDI-TOF mass spectrometry analyzers and the BioMérieux Vitek 2 antimicrobial susceptibility testing system.

Copan Diagnostics, 800-216-4016

CAP TODAY
X